Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence and Food Effect Study of TAK-438ASA in Healthy Men
NCT03456960Phase 1Completed
- Sponsor
- Takeda
- Start
- Mar 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vonoprazan + aspirin in gastric ulcer and duodenal ulcer (6 arms), sponsored by Takeda. Primary endpoints: Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration for Free Base of TAK-438, Maximum Observed Plasma Concentration for TAK-438F and 2 more. Started Mar 2018; status: completed.
02
Drugs
vonoprazan + aspirin
03
Conditions
gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on NCT03456960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03456960.